Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Toxicity of atrazine and the products of its homogeneous photocatalytic degradation on the aquatic organisms Lemna minor and Daphnia magna.

Klementová Š, Hornychová L, Šorf M, Zemanová J, Kahoun D.

Environ Sci Pollut Res Int. 2019 Sep;26(26):27259-27267. doi: 10.1007/s11356-019-05710-0. Epub 2019 Jul 18.

PMID:
31321724
2.

Novel CHK1 inhibitor MU380 exhibits significant single-agent activity in TP53-mutated chronic lymphocytic leukemia cells.

Boudny M, Zemanova J, Khirsariya P, Borsky M, Verner J, Cerna J, Oltova A, Seda V, Mraz M, Jaros J, Jaskova Z, Spunarova M, Brychtova Y, Soucek K, Drapela S, Kasparkova M, Mayer J, Paruch K, Trbusek M.

Haematologica. 2019 Apr 11. pii: haematol.2018.203430. doi: 10.3324/haematol.2018.203430. [Epub ahead of print]

3.

DNA-linked inhibitor antibody assay (DIANA) as a new method for screening influenza neuraminidase inhibitors.

Kožíšek M, Navrátil V, Rojíková K, Pokorná J, Berenguer Albiñana C, Pachl P, Zemanová J, Machara A, Šácha P, Hudlický J, Císařová I, Řezáčová P, Konvalinka J.

Biochem J. 2018 Dec 10;475(23):3847-3860. doi: 10.1042/BCJ20180764.

4.

The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase.

Mori G, Orena BS, Franch C, Mitchenall LA, Godbole AA, Rodrigues L, Aguilar-Pérez C, Zemanová J, Huszár S, Forbak M, Lane TR, Sabbah M, Deboosere N, Frita R, Vandeputte A, Hoffmann E, Russo R, Connell N, Veilleux C, Jha RK, Kumar P, Freundlich JS, Brodin P, Aínsa JA, Nagaraja V, Maxwell A, Mikušová K, Pasca MR, Ekins S.

Tuberculosis (Edinb). 2018 Sep;112:98-109. doi: 10.1016/j.tube.2018.08.004. Epub 2018 Aug 11.

PMID:
30205975
5.

Copper-related toxicity in replicating and dormant Mycobacterium tuberculosis caused by 1-hydroxy-5-R-pyridine-2(1H)-thiones.

Salina EG, Huszár S, Zemanová J, Keruchenko J, Riabova O, Kazakova E, Grigorov A, Azhikina T, Kaprelyants A, Mikušová K, Makarov V.

Metallomics. 2018 Jul 18;10(7):992-1002. doi: 10.1039/c8mt00067k.

PMID:
29946601
6.

A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK.

Chiarelli LR, Mori G, Orena BS, Esposito M, Lane T, de Jesus Lopes Ribeiro AL, Degiacomi G, Zemanová J, Szádocka S, Huszár S, Palčeková Z, Manfredi M, Gosetti F, Lelièvre J, Ballell L, Kazakova E, Makarov V, Marengo E, Mikusova K, Cole ST, Riccardi G, Ekins S, Pasca MR.

Sci Rep. 2018 Feb 16;8(1):3187. doi: 10.1038/s41598-018-21614-4.

8.

A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors.

Esposito M, Szadocka S, Degiacomi G, Orena BS, Mori G, Piano V, Boldrin F, Zemanová J, Huszár S, Barros D, Ekins S, Lelièvre J, Manganelli R, Mattevi A, Pasca MR, Riccardi G, Ballell L, Mikušová K, Chiarelli LR.

ACS Infect Dis. 2017 Jun 9;3(6):428-437. doi: 10.1021/acsinfecdis.7b00006. Epub 2017 May 11.

PMID:
28475832
9.

Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteria.

Singh V, Dhar N, Pató J, Kolly GS, Korduláková J, Forbak M, Evans JC, Székely R, Rybniker J, Palčeková Z, Zemanová J, Santi I, Signorino-Gelo F, Rodrigues L, Vocat A, Covarrubias AS, Rengifo MG, Johnsson K, Mowbray S, Buechler J, Delorme V, Brodin P, Knott GW, Aínsa JA, Warner DF, Kéri G, Mikušová K, McKinney JD, Cole ST, Mizrahi V, Hartkoorn RC.

Mol Microbiol. 2017 Jan;103(1):13-25. doi: 10.1111/mmi.13535. Epub 2016 Oct 29.

10.

Chk1 inhibition significantly potentiates activity of nucleoside analogs in TP53-mutated B-lymphoid cells.

Zemanova J, Hylse O, Collakova J, Vesely P, Oltova A, Borsky M, Zaprazna K, Kasparkova M, Janovska P, Verner J, Kohoutek J, Dzimkova M, Bryja V, Jaskova Z, Brychtova Y, Paruch K, Trbusek M.

Oncotarget. 2016 Sep 20;7(38):62091-62106. doi: 10.18632/oncotarget.11388.

11.

Assembling of the Mycobacterium tuberculosis Cell Wall Core.

Grzegorzewicz AE, de Sousa-d'Auria C, McNeil MR, Huc-Claustre E, Jones V, Petit C, Angala SK, Zemanová J, Wang Q, Belardinelli JM, Gao Q, Ishizaki Y, Mikušová K, Brennan PJ, Ronning DR, Chami M, Houssin C, Jackson M.

J Biol Chem. 2016 Sep 2;291(36):18867-79. doi: 10.1074/jbc.M116.739227. Epub 2016 Jul 14.

12.

Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and Nonreplicating Mycobacterium tuberculosis.

Karabanovich G, Zemanová J, Smutný T, Székely R, Šarkan M, Centárová I, Vocat A, Pávková I, Čonka P, Němeček J, Stolaříková J, Vejsová M, Vávrová K, Klimešová V, Hrabálek A, Pávek P, Cole ST, Mikušová K, Roh J.

J Med Chem. 2016 Mar 24;59(6):2362-80. doi: 10.1021/acs.jmedchem.5b00608. Epub 2016 Mar 15.

PMID:
26948407
13.

The p53 pathway induction is not primarily dependent on Ataxia Telangiectasia Mutated (ATM) gene activity after fludarabine treatment in chronic lymphocytic leukemia cells.

Navrkalova V, Sebejova L, Zemanova J, Jaskova Z, Trbusek M.

Leuk Lymphoma. 2013 Aug;54(8):1840-3. doi: 10.3109/10428194.2013.796056. Epub 2013 Jul 1.

PMID:
23808769
14.

[Status of bone mineral density after the long-standing application of contraception Depo-Provera].

Zeman S, Havlík P, Zemanová J, Němec D.

Ceska Gynekol. 2013 Jan;78(1):116-24. Review. Czech.

PMID:
23607391
15.

ATM mutations uniformly lead to ATM dysfunction in chronic lymphocytic leukemia: application of functional test using doxorubicin.

Navrkalova V, Sebejova L, Zemanova J, Kminkova J, Kubesova B, Malcikova J, Mraz M, Smardova J, Pavlova S, Doubek M, Brychtova Y, Potesil D, Nemethova V, Mayer J, Pospisilova S, Trbusek M.

Haematologica. 2013 Jul;98(7):1124-31. doi: 10.3324/haematol.2012.081620. Epub 2013 Apr 12.

16.

Involvement of the transcription factor STAT1 in the regulation of porcine ovarian granulosa cell functions treated and not treated with ghrelin.

Benco A, Sirotkin AV, Vasícek D, Pavlová S, Zemanová J, Kotwica J, Darlak K, Valenzuela F.

Reproduction. 2009 Sep;138(3):553-60. doi: 10.1530/REP-08-0313. Epub 2009 Jun 15.

PMID:
19528263
17.

Nickel seminal concentrations in various animals and correlation to spermatozoa quality.

Zemanová J, Lukác N, Massányi P, Trandzík J, Burócziová M, Nad P, Capcarová M, Stawarz R, Skalická M, Toman R, Koréneková B, Jakabová D.

J Vet Med A Physiol Pathol Clin Med. 2007 Aug;54(6):281-6.

PMID:
17650146
18.

Purification and some properties of thiosulfate dehydrogenase from Acidithiobacillus ferrooxidans.

Janiczek O, Zemanova J, Mandl M.

Prep Biochem Biotechnol. 2007;37(2):101-11.

PMID:
17454821
19.
20.

Pain management in children with burn injuries.

Seidlová D, Zemanová J, Cundrle I, Suchánek I.

Acta Chir Plast. 2003;45(3):81-2.

PMID:
14733250
21.

High-efficiency transformation of the pathogenic yeast Candida parapsilosis.

Zemanova J, Nosek J, Tomaska L.

Curr Genet. 2004 Mar;45(3):183-6. Epub 2003 Nov 26.

PMID:
14648114
22.

Genetic manipulation of the pathogenic yeast Candida parapsilosis.

Nosek J, Adamíková L, Zemanová J, Tomáska L, Zufferey R, Mamoun CB.

Curr Genet. 2002 Oct;42(1):27-35. Epub 2002 Sep 20.

PMID:
12420143
23.

[Early empiric antibiotic therapy of infectious complications in patients with neutropenia].

Kubesová H, Zemanová J, Vorlícek J.

Vnitr Lek. 1993 May;39(5):437-44. Czech.

PMID:
8351874
24.

[Myelodysplastic syndrome with severe thrombocytopenia and economic aspects of therapy].

Zemanová J, Matýsková M, Krahulcová E, Kubesová H.

Vnitr Lek. 1991 Nov-Dec;37(11-12):893-7. Czech.

PMID:
1796563
25.

Cell growth and population activity of Saccharomyces cerevisiae in two-stage continuous cultivation.

Beran K, Zemanová J.

Biotechnol Bioeng. 1969 Sep;11(5):853-62. No abstract available.

PMID:
5361172
26.

[Purification of mucilaginous compounds from linseed (Linum usitatissimum L.). I. Use of ion-exchange column chromatography].

Kalác J, Hornáková E, Zemanová J.

Cesk Farm. 1968 Nov;17(9):423-7. Czech. No abstract available.

PMID:
5756473
27.

Supplemental Content

Loading ...
Support Center